Lantern Pharma Inc.
LTRNDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 12, 2026
15dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How LTRN's past catalysts played out
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Lantern Pharma Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Lantern Pharma Inc.'s (LTRN) pipeline across Phase 2. Its lead program is LP-184 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Lantern Pharma Inc.'s next FDA catalyst?→
Lantern Pharma Inc.'s (LTRN) next tracked catalyst is a Earnings expected August 12, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LTRN biotech catalysts?→
Add LTRN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lantern Pharma Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.